Psychopharmacology: Insight and Comorbid SubstanceMisuse and Medication ComplianceAmong Patients With Schizophrenia
- 1 February 2001
- journal article
- Published by American Psychiatric Association Publishing in Psychiatric Services
- Vol. 52 (2) , 161-166
- https://doi.org/10.1176/appi.ps.52.2.161
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Determinants of Medication Compliance in Schizophrenia: Empirical and Clinical FindingsSchizophrenia Bulletin, 1997
- Motivation to Quit Using Substances Among Individuals With Schizophrenia: Implications for a Motivation-based Treatment ModelSchizophrenia Bulletin, 1997
- Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disordersAmerican Journal of Psychiatry, 1995
- Rating of Medication Influences (ROMI) Scale in SchizophreniaSchizophrenia Bulletin, 1994
- A self‐report Insight Scale for psychosis: reliability, validity and sensitivity to changeActa Psychiatrica Scandinavica, 1994
- Predicting Medication Compliance in a Psychotic PopulationJournal of Nervous & Mental Disease, 1993
- Subjective Response to Neuroleptics in SchizophreniaSchizophrenia Bulletin, 1993
- A two-year prospective study of treatment compliance in patients with schizophreniaPsychological Medicine, 1992
- A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validityPsychological Medicine, 1983
- Subjective Response to Antipsychotic DrugsArchives of General Psychiatry, 1981